Keryx Biopharmaceuticals, Inc. recalls Auryxia (ferric citrate) tablets, 210 mg , 200-count bottles, RX ONLY, Manufactured for and distributed by: Keryx Biopha
Recalled January 3, 2018 · FDA recall D-0133-2018 · Keryx Biopharmaceuticals
Hazard
Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle. · FDA Class III
Units
2,488 200-bottles
Sold at
Distributed nationwide in the USA
Description
Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.
Product
Auryxia (ferric citrate) tablets, 210 mg , 200-count bottles, RX ONLY, Manufactured for and distributed by: Keryx Biopharmaceticals, Inc. One Marina Park Drive, 12th Floor, Boston, MA 02210 USA. NDC 59922-631-01
Manufacturer(s)
Keryx Biopharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →